Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BROMOCRIPTINE Cause Neuroleptic malignant syndrome? 53 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Neuroleptic malignant syndrome have been filed in association with BROMOCRIPTINE (Bromocriptine mesylate). This represents 6.1% of all adverse event reports for BROMOCRIPTINE.

53
Reports of Neuroleptic malignant syndrome with BROMOCRIPTINE
6.1%
of all BROMOCRIPTINE reports
16
Deaths
42
Hospitalizations

How Dangerous Is Neuroleptic malignant syndrome From BROMOCRIPTINE?

Of the 53 reports, 16 (30.2%) resulted in death, 42 (79.2%) required hospitalization, and 11 (20.8%) were considered life-threatening.

Is Neuroleptic malignant syndrome Listed in the Official Label?

Yes, Neuroleptic malignant syndrome is listed as a known adverse reaction in the official FDA drug label for BROMOCRIPTINE.

What Other Side Effects Does BROMOCRIPTINE Cause?

Drug ineffective (138) Drug intolerance (60) Off label use (58) Headache (49) Maternal exposure during pregnancy (45) Foetal exposure during pregnancy (41) Nausea (38) Exposure during pregnancy (32) Malaise (31) Vomiting (30)

What Other Drugs Cause Neuroleptic malignant syndrome?

QUETIAPINE (1,756) OLANZAPINE (1,748) RISPERIDONE (1,258) HALOPERIDOL (1,244) ARIPIPRAZOLE (1,138) CLOZAPINE (899) LITHIUM (506) LORAZEPAM (437) PALIPERIDONE (355) VALPROIC ACID (352)

Which BROMOCRIPTINE Alternatives Have Lower Neuroleptic malignant syndrome Risk?

BROMOCRIPTINE vs BROTIZOLAM BROMOCRIPTINE vs BUCILLAMINE BROMOCRIPTINE vs BUDESONIDE BROMOCRIPTINE vs BUDESONIDE\FORMOTEROL BROMOCRIPTINE vs BUDESONIDE\FORMOTEROL\GLYCOPYRROLATE

Related Pages

BROMOCRIPTINE Full Profile All Neuroleptic malignant syndrome Reports All Drugs Causing Neuroleptic malignant syndrome BROMOCRIPTINE Demographics